招生院所：首都医科大学药学院

招生类型：学术学位（硕）

招生专业：药物分析学

研究方向名称：药物作用机制研究及寡肽类活性物质开发

电子信箱：fengwang@ccmu.edu.cn

个人简介

加州大学洛杉矶分校/加州理工学院博士后，北京药学会药品监管研究专业委员会委员，曾任博雅缉因（北京）生物科技有限公司首席科学家。主要从事寡肽类药物及干预衰老新机制研究；获授权国家发明专利8项，已发表SCI论文30篇。

教育经历

1. 博士   2009.09-2014.07    首都医科大学    药物化学

2. 学士   2005.09-2009.07    首都医科大学    药学

工作经历

1.副教授            2022.08-至今     首都医科大学药学院

2.首席科学家         2021.12-2022.05   博雅辑因（北京）

3.博士后            2019.10-2021.11   加州理工学院(Caltech)

4.博士后            2017.04-2019.09   加州大学洛杉矶分校(UCLA)

5.研究员            2014.07-2017.03   顺都药物研究所

重要学术论文：

1. Feng Wang*, Shan Li, Ting Yu Wang, George A. Lopez, Igor Antoshechkin, and Tsui Fen Chou*. "P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration." Brain communications 4, no. 4 (2022): fcac176. (*Co-corresponding author)

2. Feng Wang^*, Shan Li, William M. Rosencrans, Kai‐Wen Cheng, Gordon M. Stott, Barbara Mroczkowski, and Tsui‐Fen Chou. "Sulforaphane is Synergistic with CB‐5083 and Inhibits Colony Formation of CB-5083-Resistant HCT116 Cells." ChemMedChem 17, no. 11 (2022): e202200030. (*Co-corresponding author) IF=3.4

3. Feng Wang^*, Shan Li, Nadia Houerbi, and Tsui-Fen Chou. "Temporal proteomics reveal specific cell cycle oncoprotein downregulation by p97/VCP inhibition." Cell Chemical Biology 29, no. 3 (2022): 517-529. (*Co-corresponding author) IF=8.1

4. Feng Wang^*, Shan Li, Kai-Wen Cheng, William M. Rosencrans, and Tsui-Fen Chou^*. The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation. Pharmaceuticals , 2022, 15(2): 204. (*Co-corresponding author) IF=5.6

5. Feng Wang^#, Derek R. Moen^#, Chelsee Sauni^#, Shih-hsin Kan^#, Shan Li, Steven Q. Le, Brett Lomenick, Xiaoyi Zhang, Sean Ekins, Srikanth Singamsetty, Jill Wood, Patricia I. Dickson, and Tsui-Fen Chou. Enzyme Replacement Therapy for Mucopolysaccharidosis IIID using Recombinant Human α-N-Acetylglucosamine-6-Sulfatase in Neonatal Mice. Molecular Pharmaceutics , 2020, 18(1): 214. (#Co-first author) IF=4.9

6. Gang Zhang^#, Shan Li^#, Feng Wang^#, Amanda C. Jones^#, Alexander FG Goldberg, Benjamin Lin, Scott Virgil, Brian M. Stoltz, Raymond J. Deshaies, and Tsui-Fen Chou. A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells. European Journal of Medicinal Chemistry , 2021, 213: 113148. (#Co-first author) IF=6.5